Contineum Therapeutics, Inc. Class A Common Stock (CTNM) — Free Cash Flow Generation Index
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) has a Free Cash Flow Generation Index of 1.00x as of June 2023. Free cash flow of $40.64 Million represents 1% of operating cash flow ($40.67 Million). See Contineum Therapeutics, Inc. Class A Com current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Contineum Therapeutics, Inc. Class A Common Stock Free Cash Flow Generation Index (2023–2023)
Historical FCF Generation Index trend for Contineum Therapeutics, Inc. Class A Common Stock across 1 annual periods. Explore CTNM operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Contineum Therapeutics, Inc. Class A Common Stock (2023–2023)
Year-by-year Free Cash Flow Generation Index for Contineum Therapeutics, Inc. Class A Common Stock. For the full company profile including market capitalisation, see market value of Contineum Therapeutics, Inc. Class A Com.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.98x | $18.93 Million | $19.35 Million | $414.00K | — |